Investment Professionals
David J. Brailer, MD, PhD
Ned Brown
Sarah Chang
Thomas P. Chung
Rolf Classon
Bradley M. Fluegel
Adam Grossman
Erin L. Harrell
Aadam Hussain
Braden Kelly
Christopher McFadden
Julie Murchinson
Peter Neupert
Reid S. Perper
Jay B. Rose, MD
Joshua Saipe
Barry Smith
David A. Smith
Kevin Tseng
Jacqueline Valdez
Kay Yun
Carl Zimmerman
Sarah Chang
Associate
Health Evolution Partners Growth Fund
schang@healthevolutionpartners.com
Sarah focuses on the Services sector.
Select Prior Experience:
Goldman, Sachs & Co.: Sarah worked in the West Region Advisory group where she focused primarily in the health care sector. While at Goldman, she had an extensive experience working with senior management teams and led numerous due diligence efforts to successfully complete transactions, including the $885 million sale of ZymoGenetics to Bristol-Myers Squibb.
Education:
Bachelor’s degree, business administration, Haas School of Business, University of California, Berkeley
Fluent in Korean
